Having trouble accessing articles? Reset your cache.

Yondelis trabectedin regulatory update

Russia granted marketing approval for Yondelis trabectedin in combination with doxorubicin

Read the full 115 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE